Physician profile
Christopher Steven Blanchard
NPI 1942592613
$312,008.76
in general payments reported to CMS, 2019-2025
13 companies · $34K in 2025
The $34K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $51K · 2021: $50K · 2022: $53K · 2023: $43K · 2024: $45K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $96K · Consulting Fee: $25K · Travel and Lodging: $1,416 · Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $95,524.26 |
| Consulting Fee | $25,275.00 |
| Travel and Lodging | $1,416.14 |
| Food and Beverage | $722.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $288,093.10 | 2019-2025 | Tigershark C, Tigershark Thtl, Thunderbolt Minimally Invasive Pedicle Screw Systems |
| Spineology INC. | $17,922.63 | 2021-2022 | |
| Globus Medical, INC. | $2,616.47 | 2019 | |
| Camber Spine Technologies LLC | $927.63 | 2021 | |
| Medtronic, INC. | $863.97 | 2021 | |
| Boston Scientific Corporation | $397.68 | 2020-2024 | |
| United Orthopedics LLC | $377.88 | 2024 | |
| Providence Medical Technology, INC. | $363.26 | 2025 | |
| Medtronic USA, INC. | $166.23 | 2020 | |
| Alphatec Spine, INC | $127.08 | 2021 | |
| Cerapedics INC. | $119.00 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Aroa Biosurgery Incorporated | $17.82 | 2020 | |
| Abbott Laboratories | $16.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Blanchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.